August 2, 2007
Medical diagnostic test maker Beckman Coulter Inc. posted a 56% jump in second-quarter earnings on demand for its genetic testing systems. Net income increased to $69.4 million, or $1.09 a share, from $44.6 million, or 70 cents, a year earlier. Quarterly revenue rose nearly 12% to $689.7 million. Shares of Beckman Coulter gained 4 cents to $70.70.
March 26, 2007 |
Beckman Coulter Inc., a Fullerton company that makes testing instruments used in hospital labs, announced Sunday that it would acquire another biomedical firm, Biosite Inc., for $1.55 billion. In a combination that would strengthen its position in the medical diagnostic field, Beckman said it would acquire all the San Diego company's stock in a cash offer of $85 a share -- a 53% premium over Biosite's closing stock price of $55.38 on Friday.
January 11, 2007 |
Beckman Coulter Inc. said it would close its Palo Alto operations by 2008 and move most of the work to Indianapolis. About 220 people work at the Palo Alto site, most of which deals with making centrifuges used in laboratory equipment, the Fullerton-based company said. The action would have no effect on Beckman Coulter's 2006 results, the company said.
November 2, 2006 |
Beckman Coulter Inc. said third-quarter profit jumped 31%, mainly on proceeds from the sale of its stake in Agencourt Bioscience Corp. in July and a legal settlement. The Fullerton company earned $47.4 million, or 74 cents a share, compared with $36.2 million, or 56 cents, a year earlier. Revenue rose 6% to $631.2 million. Excluding the sale, the company's profit would have slipped to 28 cents a share, as charges including a $27.5-million payment to Roche Diagnostic Corp.
October 3, 2006 |
Beckman Coulter Inc. said it would buy Lumigen Inc., a maker of chemicals used in diagnostics and scientific research, for $185 million in cash. The transaction is expected to have no effect on Beckman Coulter's financial results this year and to add at least 2 cents a share to earnings next year, the Fullerton company said. The laboratory equipment maker accounted for 40% of Southfield, Mich.-based Lumigen's $33 million in revenue last year, the companies said.
August 3, 2006 |
Beckman Coulter Inc. said its second-quarter profit fell on higher expenses and a decline in sales in Japan and China. The Fullerton maker of laboratory equipment, genetic testing kits and products used in drug discovery posted net income of $44.6 million, or 70 cents a share, down from $55.2 million, or 85 cents, a year ago. Sales fell to $616.3 million from $618.8 million last year. Beckman revised its outlook downward for the rest of the year to reflect slow growth in Asia.